Robeco Institutional Asset Management
RCUS icon

Robeco Institutional Asset Management’s Arcus Biosciences RCUS Stock Holding History

Robeco Institutional Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,143
Closed -$23.2K – 1052
2023
Q2 		$23.2K Sell
1,143
-54,366
-98% -$1.04M ﹤0.01% 1021
2023
Q1 		$1.01M Buy
55,509
+9,516
+21% +$182K ﹤0.01% 774
2022
Q4 		$951K Buy
45,993
+15,890
+53% +$437K ﹤0.01% 784
2022
Q3 		$788K Buy
30,103
+9,428
+46% +$249K ﹤0.01% 717
2022
Q2 		$524K Buy
+20,675
New +$506K ﹤0.01% 764

Other funds holding RCUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Robeco Institutional Asset Management's RCUS Position: Q3 2023 in Review

Robeco Institutional Asset Management sold out of Arcus Biosciences (RCUS) in Q3 2023, closing a stake of 1,143 shares — an estimated $23.2K sold.

Robeco Institutional Asset Management first reported a position in RCUS in Q2 2022 and held it in 5 quarters. The position peaked at $1.01M in Q1 2023. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2023.

  • Robeco Institutional Asset Management reported no remaining Arcus Biosciences position as of Q3 2023 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 1,143 Arcus Biosciences shares in Q3 2023, an estimated $23.2K.
  • Robeco Institutional Asset Management first reported a position in Arcus Biosciences in Q2 2022 and held it in 5 quarters.
  • Robeco Institutional Asset Management's Arcus Biosciences position peaked at $1.01M in Q1 2023.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2023, filed 24 Oct 2023.